Benefits of Short-Term Professional Continuous Glucose Monitoring in Clinical Practice
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: The clinical utility of short-term professional continuous glucose monitoring (CGM) is uncertain. Subjects and Methods: This is a retrospective review of 121 consecutive insulin-treated patients seen in a university-based subspecialty clinic who completed a 72–120-h professional CGM study. Based on the indications for the study, patients were divided into three groups: hyperglycemia (Hyper) ( n =51), widely fluctuating glycemia (Fluctuating) ( n =50), or hypoglycemia (Hypo) ( n =20). Hemoglobin A1c (A1c) was compared before and 3–6 months after CGM. Hypoglycemia frequency was recorded by patients' self-report. Results: Among the entire cohort, the A1c level dropped a small amount (0.18%; P =0.04). In the Hyper group, the A1c level fell from 9.0±1.1% to 8.6±1.2% ( P <0.02). In the Fluctuating group, there was no change (from 8.0±1.0% to 8.0±0.9%). The A1c level of the Hypo group patients did not change (7.6±1.1% before and after), but 14 of 20 (70%; P <0.01) had a drop in self-reported frequency of hypoglycemia. For the whole cohort, the drop in A1c level was correlated with the initial A1c value ( r =0.54, P <0.01). Patients with an initial A1c level of >9.0% saw a drop of 0.7% (from 10.2±1.1% to 9.4±1.1%; P <0.01), and those with an A1c level of >7.5% saw a drop of 0.4% (from 8.9±1.2% to 8.5±1.1%; P =0.01). Subgroup analysis showed that patients with type 1 diabetes had a drop in A1c level that was not statistically significant. However, type 1 diabetes patients in the Hypo group did have a decrease in self-reported hypoglycemia (11 of 16 [68%]; P =0.03). Conclusions: Professional CGM can lead to a lowering of elevated A1c levels in insulin-treated patients, especially those with type 2 diabetes. There also appears to be benefit in decreasing self-reported hypoglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring
Xing, D., Kollman, C., Beck, R. W., Tamborlane, W. V., Laffel, L., Buckingham, B. A., Wilson, D. M., Weinzimer, S., Fiallo-Scharer, R., & Ruedy for the Juvenile Diabetes Research Foundation Continuo, K. J. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0156 · Cited by 131
Cited by
Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes
Rodbard, D. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0035 · Cited by 458
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Fonseca, V. A., Grunberger, G., Anhalt, H., Bailey, T. S., Blevins, T., Garg, S. K., Handelsman, Y., Hirsch, I. B., Orzeck, E. A., Roberts, V. L., et al. (2016) · Endocrine Practice · doi:10.4158/ep161392.cs · Cited by 195
“Several small-scale studies have shown that professional CGM can lead to reductions in A1C, weight loss, and/or reductions in incidence of hypoglycemia in patients with T2D when the clinician uses the data to guide therapeutic changes (27-32).”
BackgroundWright, L. A.-C., & Hirsch, I. B. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0029 · Cited by 178
“Others have reported an improvement on A1C in hyperglycemic patients with T1DM(78) and both T1 and T2DM,(78,79) and in patients with T2DM, having mainly hypoglycemia(78); in this same study, there was no change in A1C in patients classified as having fluctuating glucose levels with either form of DM.(79) Durability of…”
BackgroundInfluentialAjjan, R. A., Jackson, N., & Thomson, S. A. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827456 · Cited by 79
Furler, J., O'Neal, D., Speight, J., Blackberry, I., Manski-Nankervis, J.-A., Thuraisingam, S., de La Rue, K., Ginnivan, L., Doyle, R., Holmes-Truscott, E., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30385-7 · Cited by 55
Metadata
- Authors
- Leinung, M., Nardacci, E., Patel, N., Bettadahalli, S., Paika, K., & Thompson, S.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2013-09
- Volume
- 15
- Issue
- 9
- Pages
- 744-747
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2057748631
- Cited by
- 26
- References
- 3
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.